Elekta AB (publ) (EKTA-B.ST)

STO • Currency in SEK

kr 47.04

+kr 0.40

+0.86%

Last Update: 29 Aug 2025, 15:29

kr 17.27B

Market Cap

0.00

P/E Ratio (TTM)

5.10%

Forward Dividend Yield

kr 40.64 - kr 73.60

52 Week Range

EKTA-B.ST Stock Price Chart

Explore Elekta AB (publ) interactive price chart. Choose custom timeframes to analyze EKTA-B.ST price movements and trends.

EKTA-B.ST Company Profile

Discover essential business fundamentals and corporate details for Elekta AB (publ) (EKTA-B.ST) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

3 Jan 2000

Employees

4.54K

Website

https://www.elekta.com

CEO

Jonas Bolander

Description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

EKTA-B.ST Financial Timeline

Browse a chronological timeline of Elekta AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 May 2026

Upcoming earnings on 5 Mar 2026

Dividend declared on 5 Mar 2026

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend will be paid on 11 Mar 2026.

Upcoming earnings on 26 Nov 2025

EPS estimate is kr 0.67, while revenue estimate is kr 4.24B.

Dividend declared on 5 Sept 2025

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend will be paid on 11 Sept 2025.

Earnings released on 28 Aug 2025

EPS came in at kr 0.18 falling short of the estimated kr 0.73 by -74.77%, while revenue for the quarter reached kr 3.83B , missing expectations by -10.37%.

Earnings released on 28 Aug 2025

EPS came in at kr 0.31 falling short of the estimated kr 0.67 by -53.67%, while revenue for the quarter reached kr 3.66B , missing expectations by -13.71%.

Earnings released on 28 May 2025

EPS came in at kr 1.11 falling short of the estimated kr 1.46 by -23.97%, while revenue for the quarter reached kr 5.16B , beating expectations by +27.87%.

Dividend declared on 6 Mar 2025

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 12 Mar 2025.

Earnings released on 21 Feb 2025

EPS came in at kr 0.94 falling short of the estimated kr 1.05 by -10.48%, while revenue for the quarter reached kr 4.70B , missing expectations by -12.68%.

Earnings released on 27 Nov 2024

EPS came in at kr 0.64 falling short of the estimated kr 0.89 by -27.75%, while revenue for the quarter reached kr 4.34B , missing expectations by -4.69%.

Dividend declared on 6 Sept 2024

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 12 Sept 2024.

Earnings released on 28 Aug 2024

EPS came in at kr 0.41 surpassing the estimated kr 0.34 by +20.59%, while revenue for the quarter reached kr 3.83B , beating expectations by +4.49%.

Earnings released on 5 Jun 2024

EPS came in at kr 1.15 falling short of the estimated kr 1.48 by -22.30%, while revenue for the quarter reached kr 5.02B , beating expectations by +2.59%.

Earnings released on 29 Feb 2024

EPS came in at kr 0.80 falling short of the estimated kr 0.94 by -14.89%, while revenue for the quarter reached kr 4.54B , missing expectations by -1.19%.

Dividend declared on 26 Feb 2024

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 1 Mar 2024.

Earnings released on 30 Nov 2023

EPS came in at kr 0.94 matching the estimated kr 0.94, while revenue for the quarter reached kr 4.73B , beating expectations by +4.19%.

Dividend declared on 25 Aug 2023

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 31 Aug 2023.

Earnings released on 24 Aug 2023

EPS came in at kr 0.65 surpassing the estimated kr 0.43 by +51.16%, while revenue for the quarter reached kr 3.83B , missing expectations by -15.58%.

Earnings released on 25 May 2023

EPS came in at kr 1.53 surpassing the estimated kr 1.24 by +23.39%, while revenue for the quarter reached kr 5.12B , beating expectations by +4.28%.

Earnings released on 24 Feb 2023

EPS came in at kr 0.83 surpassing the estimated kr 0.67 by +23.88%, while revenue for the quarter reached kr 4.34B , beating expectations by +7.21%.

Dividend declared on 24 Feb 2023

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 2 Mar 2023.

Earnings released on 24 Nov 2022

EPS came in at kr 0.55 surpassing the estimated kr 0.53 by +3.77%, while revenue for the quarter reached kr 4.08B , beating expectations by +0.75%.

Dividend declared on 26 Aug 2022

A dividend of kr 1.20 per share was announced, adjusted to kr 1.20. The dividend was paid on 1 Sept 2022.

Earnings released on 25 Aug 2022

EPS came in at kr 0.16 falling short of the estimated kr 0.58 by -72.41%, while revenue for the quarter reached kr 3.33B , beating expectations by +0.22%.

Earnings released on 25 May 2022

EPS came in at kr 1.09 surpassing the estimated kr 0.87 by +25.29%, while revenue for the quarter reached kr 4.24B , beating expectations by +4.81%.

Dividend declared on 25 Feb 2022

A dividend of kr 1.10 per share was announced, adjusted to kr 1.10. The dividend was paid on 3 Mar 2022.

Earnings released on 24 Feb 2022

EPS came in at kr 0.60 falling short of the estimated kr 0.68 by -11.76%, while revenue for the quarter reached kr 3.60B , missing expectations by -1.92%.

Earnings released on 25 Nov 2021

EPS came in at kr 1.00 surpassing the estimated kr 0.76 by +31.58%, while revenue for the quarter reached kr 3.70B .

Dividend declared on 26 Aug 2021

A dividend of kr 1.10 per share was announced, adjusted to kr 1.10. The dividend was paid on 1 Sept 2021.

Earnings released on 25 Aug 2021

EPS came in at kr 0.33 falling short of the estimated kr 0.63 by -47.62%, while revenue for the quarter reached kr 3.01B .

Earnings released on 28 May 2021

EPS came in at kr 0.89 falling short of the estimated kr 0.93 by -4.30%, while revenue for the quarter reached kr 3.67B .

Dividend declared on 19 Apr 2021

A dividend of kr 0.90 per share was announced, adjusted to kr 0.90. The dividend was paid on 23 Apr 2021.

Earnings released on 25 Feb 2021

EPS came in at kr 0.84 falling short of the estimated kr 0.85 by -1.18%, while revenue for the quarter reached kr 3.58B .

Earnings released on 26 Nov 2020

EPS came in at kr 0.98 surpassing the estimated kr 0.87 by +12.64%, while revenue for the quarter reached kr 3.53B .

EKTA-B.ST Stock Performance

Access detailed EKTA-B.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.